‹ BackHN Continuity

Thread

Claude discovers a novel enzyme system with CRISPR-like repeats

780 points · 805 comments · raahelb

  1. ryanschaefer · · focus · HN ↗
    I’m confused why AI companies are using agents in-house for this type of research instead of partnering externally.

    I guess the improvement loop is tighter and they have more control over how discoveries can be used for marketing?

    But, in my mind, it begins to feel like they are setting themselves up to be “everything” companies instead of focusing on their core product…

    1. 6thbit · · focus · HN ↗
      Lands as an active threat. Maybe they're serious about this research or not, but for sure medical companies doing this sort of research will consider upping their AI budget and connecting their labs, etc. to avoid "falling behind".

      So, the AI labs benefit either from achieving something they could market or from the peer-pressure imposed to companies in the sectors they get their nose in.

Open on Hacker News to reply ↗

Unofficial Hacker News client; not affiliated with Y Combinator.